AIP and Cardiovascular and Atherosclerotic Risk: A Simple TG/HDL Number That Tracks Artery Health

Today we’ll explain what the Atherogenic Index of Plasma (AIP) means for heart and artery health, and how to use the TG/HDL calculator in this article to track your progress.

🎧 ▶️ Press the play button below to listen in English.

🇨🇳 中文（简体）

欢迎收听——今天我们会用通俗的话讲清楚动脉粥样硬化指数（AIP）与心血管和动脉健康的关系，并教你如何使用本文的甘油三酯/高密度脂蛋白（TG/HDL）计算器来追踪改善进展。

请按下方的播放按钮收听。

🇪🇸 Spanish (Latinoamérica)

Bienvenido—hoy vamos a explicar qué significa el índice aterogénico del plasma (AIP) para la salud del corazón y las arterias, y cómo usar la calculadora de TG/HDL de este artículo para seguir tu progreso.

Presiona el botón de reproducir para escuchar.

I. Introduction

If you want one number that “summarizes” a common high-risk lipid pattern, Atherogenic Index of Plasma (AIP) is one of the simplest.

AIP is built from two routine lab values—triglycerides (TG) and HDL cholesterol (HDL-C)—using a logarithmic ratio.

Garg et al. (2020) describe AIP as the log transformation of TG/HDL-C, used as a surrogate marker related to small, dense LDL patterns.

In a large stroke cohort, Qu et al. (2024) state the formula directly as log[TG (mg/dL) / HDL-C (mg/dL)].
In a CAD meta-analysis, Wu et al. (2021) define AIP as the logarithm of the TG/HDL-C ratio in molar units and emphasize its association with atherosclerotic burden.

This article includes an AIP calculator so readers can enter their TG and HDL values and get their AIP instantly—and then use it as a simple “trend marker” while working on improving cardiometabolic health.

Why does this matter clinically? Because higher AIP keeps showing up alongside higher risk in multiple artery territories:

• Coronary artery disease (CAD): In their meta-analysis, Wu et al. (2021) found that higher AIP was linked with higher odds of CAD, including when comparing the highest vs lowest AIP categories.
• Carotid stenosis (neck arteries): Garg et al. (2020) reported that higher AIP quartiles were independently associated with symptomatic carotid artery stenosis.
• New-onset stroke: Qu et al. (2024) found stroke risk increased stepwise across AIP quartiles, even after adjusting for confounders.
• Peripheral arterial disease (PAD): In an editorial focused on PAD prediction, Hohneck and Weingaertner (2025) discuss findings from NHANES work and note a reported 30% increase in PAD likelihood per unit increase in AIP.

---

II. What is CCVD/ASCVD, and why are these diseases grouped together?

Even though the heart, brain, neck, legs, and aorta are anatomically far apart, many of the major diseases that affect them are grouped together because they often share the same underlying arterial problem.

The big umbrella: Atherosclerotic Cardiovascular Disease (ASCVD)

ASCVD commonly refers to a family of arterial diseases driven by atherosclerosis—plaque buildup and arterial-wall damage that can narrow vessels, reduce blood flow, and sometimes trigger sudden events.

In a PAD-focused editorial, Hohneck and Weingaertner (2025) use the term ASCVD and give examples like coronary artery disease (CAD) and stroke, showing how these conditions sit under the same umbrella.

Likewise, Wu et al. (2021) point out that the basic pathological feature of CAD is systemic inflammation-related atherosclerosis, which is a useful “unifying concept” for why these diseases cluster.

Why group them if they occur in different places?

Because the common denominator is not the location—it’s the artery-wall process.

• In the heart, atherosclerosis shows up as CAD.
• In the neck, it can show up as carotid stenosis, which raises stroke risk.
• In the brain, it can show up as an ischemic stroke and other cerebrovascular diseases.
• In the legs, it shows up as PAD.
• In the aorta, it can show up as calcification/atherosclerotic burden.

The body doesn’t develop atherosclerosis “one artery at a time” in isolation—it tends to reflect systemic metabolic and inflammatory pressures acting across the whole arterial tree.

What AIP adds to this picture

AIP is appealing because it reflects the balance between more atherogenic and more protective lipid forces. Hohneck and Weingaertner (2025) explicitly describe AIP as reflecting the ratio of atherogenic to antiatherogenic lipoproteins, and they show how it’s calculated as log10(TG/HDL-C).

So when you use AIP, you’re not just thinking “heart risk” or “stroke risk” in a silo—you’re using a marker that has been linked to multiple ASCVD endpoints across different vascular beds in the studies you’ll see later in this article (e.g., Wu et al., 2021; Garg et al., 2020; Qu et al., 2024; Hohneck and Weingaertner, 2025).

III. The Effects of a High Triglyceride and Low HDL on CVD Formation

AIP rises when triglycerides are higher and/or HDL is lower—a pattern often called atherogenic dyslipidemia. One reason AIP gets so much attention is that it can act as a practical “fingerprint” for more harmful lipoprotein patterns.

For example, Garg et al. (2020) explain that AIP (log[TG/HDL-C]) can serve as a surrogate marker for small, dense LDL (sdLDL) using routine lipid values.

Here’s why this high triglyceride and low HDL pattern can accelerate atherosclerosis:

High triglycerides often signal more triglyceride-rich particles circulating in the blood. These particles (and their remnants) can interact with the artery wall and promote plaque formation.

Qu et al. (2024) summarize proposed mechanisms for stroke risk and note that triglycerides appear linked to vascular inflammation and subclinical atherosclerosis, and that triglyceride-rich lipoproteins (like chylomicrons and VLDL) may play a role in atherosclerotic lesion formation.

High triglycerides tend to travel with smaller, denser, more atherogenic particles. Xu et al. (2024) state that elevated TG and low HDL are strong markers of CVD, and that elevated TG can lead to increased small dense LDL, ultimately raising cardiovascular risk.

Along the same lines, Hohneck and Weingaertner (2025) note that AIP indirectly reflects LDL particle size/density, with higher AIP linked to smaller, denser LDL particles, which are considered more atherogenic.

Small, dense LDL is “stickier” and more artery-irritating. Garg et al. (2020) outline why sdLDL is especially atherogenic: reduced clearance from the bloodstream, more oxidation, stronger binding to the endothelium, easier penetration into the artery wall, and greater uptake by macrophages—steps that drive foam cell formation, an early stage of atherogenesis.

Once plaques exist, lipid imbalance also relates to plaque “behavior,” not just plaque “amount.” In a study of patients with acute coronary syndrome, Wu et al. (2024) frame AIP as reflecting an imbalance between TG and HDL, both critical in atherogenesis, and describe how higher AIP implies a predominance of smaller, denser, more atherogenic particles.

Where do diet and exercise fit in? A high-glycemic, insulin-spiking diet and low physical activity commonly raise triglycerides and lower HDL (especially in insulin resistance).

In the stroke cohort paper, Qu et al. (2024) explicitly position AIP as a marker of dyslipidemia and as a predictor of insulin resistance risk—exactly the metabolic “soil” in which high TG/low HDL patterns tend to grow.

---

IV. High AIP tends to track with higher cardiovascular and atherosclerotic risk (in multiple “artery territories”)

Quick decoder (so the study numbers make sense)

You’ll see a few research terms repeated:

• Quartiles (Q1–Q4): split the study population into 4 equal groups by AIP.
  Q1 = lowest 25% (best) → Q4 = highest 25% (worst).
• RR (Relative Risk): “how many times the risk.”
  RR 2.0 ≈ is about double the risk.
• OR (Odds Ratio): “how many times the odds.”
  OR 2.0 ≈ is about twice as likely (a good rule of thumb for readers).
• HR (Hazard Ratio): risk over time during follow-up.
  HR 1.8 ≈ ~80% higher risk over time.

---

A) Coronary artery disease (CAD): higher AIP → more CAD

Wu et al. (2021) meta-analysis pooled 10 observational studies and evaluated AIP two ways:

1) AIP as a continuous variable (a number on a scale)
This means AIP is treated like blood pressure or glucose—it can move up or down, not just “high vs low.”

• RR 2.10 per 1 standard deviation (SD) increase in AIP Atherogenic Index of Plasma and…

Plain meaning: when AIP rises by a typical meaningful step (1 SD) in that population, CAD risk rises a lot in the pooled data.

2) AIP as categories (highest vs lowest)

• RR 2.35 for the highest vs the lowest AIP category

In combined studies, people with higher AIP consistently had much more CAD than those with low AIP.

---

B) If you already have CAD: higher AIP → more serious outcomes

Rabiee Rad et al. (2024) conducted a meta-analysis of 16 studies (~20,833 CAD patients) to assess whether AIP predicts outcomes after CAD is present.

• MACE RR 1.63 (highest vs lowest AIP)
• CV death RR 1.79
• MI (heart attack) RR 2.21
• Revascularization RR 1.62
• No-reflow RR 3.12

What these means:

• MACE = “Major Adverse Cardiovascular Events” (the big bad outcomes: heart attack, stroke, cardiovascular death, and sometimes procedures). It’s used because it captures what actually harms or kills people.
• Revascularization = restoring blood flow (usually stent/angioplasty or bypass surgery).
• No-reflow = after opening a blocked artery, blood still doesn’t perfuse well downstream, which can worsen heart-muscle injury.

High AIP doesn’t just line up with “having CAD.” It lines up with worse outcomes in people who already have CAD.

---

C) Plaque vulnerability: why plaque “type” matters (stable vs unstable)

Not all plaques are equally dangerous.

• Stable plaques tend to have a thicker protective cap and are less likely to suddenly trigger a clot.
• Unstable plaques are more inflamed, have a fragile surface, and can tear open, causing a sudden clot and a heart attack.

Wu et al. (2024) used OCT imaging inside coronary arteries (acute coronary syndrome patients). Higher AIP quartiles were linked with more “dangerous plaque features,” including:

• TCFA, macrophage accumulation, plaque rupture, plaque erosion
• Highest vs lowest quartile:
  • TCFA OR 11.13
  • Plaque rupture OR 5.33 The relationship between athero…

Definitions that matter:

• TCFA = Thin-Cap Fibroatheroma: a plaque with a thin fibrous cap over a lipid-rich core—more likely to rupture.
• Plaque rupture is dangerous because it can trigger sudden clot formation that blocks the artery and causes a heart attack.

Bottom line: AIP isn’t only linked with “more plaque.” It’s linked with more unstable plaque in imaging studies.

---

D) Carotid artery stenosis: neck-artery narrowing linked with stroke

Garg et al. (2020) found that higher AIP quartiles were independently linked with symptomatic carotid artery stenosis in ischemic stroke patients.

What is carotid stenosis?
Narrowing of the major neck arteries that feed the brain.

Symptoms people should know (often TIA-like):

• sudden one-sided weakness or numbness
• sudden trouble speaking/understanding
• sudden vision loss in one eye (“curtain” effect)
• sudden severe imbalance/dizziness

Bottom line: High AIP lined up with clinically important carotid disease, a major stroke-risk pathway.

---

E) New-onset stroke: AIP predicts stroke over time

Qu et al. (2024) followed participants long-term and found that stroke risk rose stepwise by AIP quartile:

• vs Q1 (lowest AIP): Q2 HR 1.34, Q3 HR 1.52, Q4 HR 1.84

Reminder: HR is “risk over time.”
Higher HR means strokes accumulated faster in the higher-AIP groups during follow-up.

Bottom line: AIP isn’t just cross-sectional. In that cohort, it helped predict future strokes.

---

F) Abdominal aortic calcification (AAC): a “pipeline” warning sign

Xu et al. (2024) linked AIP with extensive abdominal aortic calcification (a marker of long-standing atherosclerotic burden and arterial stiffening):

• Extensive AAC odds OR 2.00 per unit increase in AIP
• Highest vs lowest AIP tertile: OR 1.73

Why lay readers should care:

• Aortic calcification is a common finding, especially as people get older and in those with insulin resistance, diabetes, smoking history, or long-standing lipid problems.
• It usually means the aorta has been exposed to years of artery-wall stress, and it often reflects higher atherosclerotic burden (more plaque/calcified plaque) and stiffer arteries.
• As calcification progresses, the aorta can become less elastic, which may contribute to higher systolic blood pressure, wider pulse pressure, and greater strain on the heart over time.
• Most people feel no symptoms from calcification itself—but it can be a “warning sign” that the same atherosclerotic process may also be affecting the heart, brain, and leg arteries, which is why clinicians take it seriously.

Bottom line: Higher AIP tracked with more atherosclerotic burden in the aorta—a high-stakes location.

---

G) Peripheral arterial disease (PAD): why it can lead to wounds, gangrene, amputation

Hohneck and Weingaertner (2025) discuss AIP as a practical PAD risk marker and summarize NHANES findings consistent with higher PAD likelihood as AIP increases.

What PAD looks like:

• leg pain/cramping with walking that improves with rest (claudication)
• cold feet, weak pulses
• slow-healing foot sores

Why PAD is serious:

• poor blood flow → non-healing wounds
• wounds get infected → gangrene
• severe tissue loss/infection → amputation risk

Bottom line: PAD is a “silent” atherosclerosis problem that can become devastating—AIP may help flag risk earlier.

---

Section Summary

Across multiple studies and artery locations, higher AIP tends to travel with higher atherosclerotic disease risk—CAD, stroke pathways (carotids/brain), aortic calcification, and PAD.

The practical win is that AIP is built from two routine numbers (TG and HDL), which makes it cheap, repeatable, and trackable.

V. The AIP Calculator

The AIP calculator can turn two routine lipid numbers, triglycerides and HDL, into one trackable index.

How to use the AIP calculator (step-by-step)

1. Find your TG and HDL-C on your lipid panel (preferably fasting, if that’s how your labs are typically done).
2. Enter the numbers exactly as shown on your report.
3. Choose the correct units (mg/dL vs mmol/L) if the calculator asks.
4. Click Calculate to get your AIP.

How to interpret your AIP output (simple, practical)

Common AIP risk categories (rule of thumb)

• AIP < 0.11 → Lower (favorable) risk
• AIP 0.11 to 0.21 → Intermediate risk
• AIP > 0.21 → Higher (unfavorable) risk PMC

“Good/favorable” AIP usually means: TG is relatively low and/or HDL is relatively higher.

“High/unfavorable” AIP usually means: TG is high and/or HDL is low—an atherogenic pattern that tends to travel with higher cardiovascular risk in studies. PMC

• Lower AIP is generally better than higher AIP.
• AIP is most useful as a trend marker:
  • Compare your AIP to your own prior results, not just a single snapshot.
  • Watch whether AIP is moving downward over time as your TG/HDL pattern improves.

And remember what AIP “means” conceptually: it reflects the triglyceride to HDL balance Triglyceride to-HDL balance, or the balance between atherogenic and antiatherogenic lipoproteins.

---

Once you have your AIP number, the next question is: “What do I do with it?”

Use AIP the same way you’d use a scale, a waist measurement, or a resting heart rate: as feedback.

VI. Treat AIP as a Progress Marker (Not an Omen)

AIP is tightly tied to the metabolic environment that drives atherosclerosis. In their cohort work, Qu et al. (2024) describe AIP as a marker of dyslipidemia and note that it can also predict insulin resistance risk—exactly the metabolic direction most people want to reverse.

So instead of treating AIP as a label, treat it as a signal you can influence.

How to monitor AIP during lifestyle change

• Pick a consistent interval.
  A practical cadence is every 8–12 weeks early on (enough time for TG/HDL to respond), then less often once you’re stable.
• Keep testing conditions consistent.
  Try to repeat labs under similar conditions (fasting vs non-fasting, time of day, recent alcohol intake, recent illness, and unusual training weeks).
• Track the components, not just the score.
  Your AIP changes because:
  • TG moved,
  • HDL moved,
  • or both.
    Seeing which one changed helps you troubleshoot.

What “progress” usually looks like

You’re usually moving in the right direction when:

• Triglycerides trend down
• HDL trends up or holds steady
• AIP trends down

Even modest improvements can matter because atherosclerosis is a modifiable process. Plaque biology, inflammation, and lipid trafficking respond to what you do repeatedly—food choices, movement, sleep, and weight/waist change.

It’s never too late

The strongest mindset to keep is this: CVD processes are modifiable, and it’s never too late to start shifting your trajectory.
AIP gives you a simple number you can recheck and use as proof that your body is responding—especially when you make changes that tend to lower TG and improve the TG/HDL pattern over time.

If you want, I’ll continue with the next section that translates this into a clear “action plan” framework (diet, activity, and a simple tracking table readers can copy) while keeping the tone non-alarmist and practical.

VII. How to Improve AIP (Action Plan)

AIP improves when you reverse the two drivers that push it up:

• Lower triglycerides (TG) → usually means improving insulin resistance and reducing “TG-producing” inputs (especially sugar/refined carbs and excess alcohol).
• Raise (or preserve) HDL → most reliably improved by exercise, especially a mix of aerobic + resistance training.

• 102 Easy Ways to Lower Postprandial Blood Sugar Without Meds
• Articles On How To Lower Postprandial Sugar
• Heart-Healthy Workouts And More: The Ultimate Guide to Reducing Cardiac Age
• See more articles below on how to lower blood sugar

Lifestyle is the recommended starting point for high triglycerides in major guidelines.

---

1) Diet plan (aimed at lowering TG and improving insulin resistance)

Your “big 3” targets

• Cut added sugar (sweet drinks, desserts, candy, sweetened coffee drinks). Limiting added sugar is a core triglyceride-lowering recommendation.
• Reduce refined starches (white bread, white rice, many cereals, pastries). Replacing refined carbs with whole-food carbs is repeatedly recommended for triglyceride management.
• Limit alcohol (or avoid if TG is high). Alcohol can significantly raise triglycerides in some people.

Replace-with list (simple swaps that usually move TG/HDL the right way)

• Swap sugary snacks → Greek yogurt, nuts, berries
• Swap refined carbs → beans/lentils, oats, vegetables, intact whole grains
• Swap frequent “liquid carbs” → water, unsweetened tea/coffee
• Choose healthier fats (olive oil, nuts, seeds, fatty fish) instead of “ultra-processed” fat-and-sugar combos; AHA dietary guidance emphasizes minimally processed foods and minimizing added sugars. www.heart.org

The waistline link (because insulin resistance lives here)

• If you have belly fat, even modest weight/waist reduction can improve insulin resistance and triglycerides. Controlling weight is listed among key TG-lowering steps in NIH/MedlinePlus guidance.

• What Does Waist Circumference Really Measure?
• A New Definition Of Obesity Is Making Medicine Better

---

2) Activity plan (aimed at raising HDL and improving insulin sensitivity)

The weekly minimum that shows up in diabetes/cardiometabolic guidance

• 150 minutes/week of moderate-intensity aerobic activity (or equivalent), spread across the week.
• Add 2–3 days/week of resistance training (build muscle = better glucose disposal). PMC

Simple activity “prescriptions” that work in real life

• After-meal walking: 10–15 minutes after one or two meals per day (helps blunt glucose spikes and supports insulin sensitivity).
• Zone 2 base: brisk walking, cycling, or elliptical where you can talk but not sing, 30 minutes most days.
• Strength basics (20–30 min): squats/sit-to-stands, hinges (deadlift pattern), pushes, pulls, carries.

Why this helps AIP

• Aerobic + resistance training improves glycemic control/insulin sensitivity, which supports lower triglycerides over time and helps preserve/improve HDL. PMC

---

3) “AIP Improvement Checklist” (use this as your weekly scoreboard)

Pick 2–3 changes for the next 8 weeks (don’t try to perfect everything at once):

Diet (choose 2)

• ☐ No sugar-sweetened drinks
• ☐ Dessert ≤ 2 times/week
• ☐ Refined starch only 1 serving/day (or less)
• ☐ 1–2 cups/day legumes or oats
• ☐ Alcohol: none (or minimal)

Activity (choose 2)

• ☐ 150 min/week aerobic (30 min × 5 days) American Diabetes Association
• ☐ Strength training 2 days/week PMC
• ☐ 10–15 min walk after 1 meal/day

Recheck plan

• ☐ Repeat fasting TG + HDL (and AIP) in 8–12 weeks under similar conditions (alcohol and illness can distort TG; fasting instructions often matter). MedlinePlus

---

4) A simple tracking table readers can copy

Copy/paste this into Notes, Google Docs, or a spreadsheet:

Date	TG	HDL	AIP	Weight	Waist	Steps/day (avg)	Aerobic min/week	Strength days/week	Added sugar (Y/N)	Alcohol (servings/week)	Notes (sleep/illness/travel)
Baseline
Week 4
Week 8–12 (recheck labs)

How to use it

• Your goal is not “perfect days.” Your goal is a trend:
  • TG trending down
  • HDL trending up or stable
  • AIP trending down

---

Safety note

If you have diabetes, heart disease, very high triglycerides, or take glucose-lowering medications, talk with your clinician before major diet or exercise changes.

Don’t Get Sick!

Medically Reviewed by Dr. Jesse Santiano, MD
Dr. Santiano is a retired internist and emergency physician with extensive clinical experience in metabolic health, cardiovascular prevention, and lifestyle medicine. He reviews all medical content on this site to ensure accuracy, clarity, and safe application for readers. This article is for educational purposes and is not a substitute for personal medical care.

💡 Support This Work

Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.

🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!

Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.

Related:

1. Atherogenic Index (AIP): Meaning, Clinical Uses and Calculator
2. Small Dense LDL: What It Means And How To Improve It
3. ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
4. LDL Particle Number Explained: A Better Marker Than LDL Cholesterol
5. TG/HDL Ratio Explained: What It Means and How to Improve It
6. HDL Function Explained: Good vs Bad HDL
7. High Triglycerides: Causes, Dangers, And How To Lower
8. Metabolic Health Check: Your Metabolic Digest (What It Means + How to Improve It)
9. New Science Debunks the Dangers of Saturated Fats on Heart Disease
10. Machine Learning Finds Your Hidden Heart Disease Risks
11. ApoB Reveals Hidden Heart Disease And Diabetes Risk Early
12. How to Interpret ApoB and ApoA1 Results
13. ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
14. CAC And CTA Scans Help Detect Heart Disease Early
15. ApoB and ApoA1 Best Predict Heart Attack: How To Get Tested
16. ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
17. Heart Attack Risk? Use The Framingham Risk Calculator And Lower It Now!
18. Discover Your Cardiac Age with This Free Calculator
19. Heart Rate Recovery Reveals Hidden Secrets About Your Heart
20. Drink Coffee At This Time To Slash Heart Attack Risk
21. The FODMAP Trap That Mimics Heart Attacks During Exercise
22. The Hidden Link Between High Blood Sugar and Heart Attacks
23. Strep From the Mouth and Blood and Sudden Cardiac Death — What You Need to Know
24. Lithium’s Hidden Power: Unlocking Protection Against Cardiovascular Disease
25. How Reduced Blood Sugar Lowers BP And Cardiovascular Risks
26. Cholesterol and Blood Sugar: The Strong Link

Articles on how to lower postprandial sugar

1. Office Hacks for Blood Sugar Balance: Quick Moves You’ll Love
2. Conquer Sugar Spikes With A Simple Morning Green Tea Ritual
3. Antioxidants And Timing: How To Reduce Blood Sugar-Related Oxidative Stress
4. Mastering Diabetes: Prevent Hypoglycemia with Smart Medication Adjustments
5. The Simple Way To Keep Blood Sugar Low: Breakfast
6. Meal Timing: A Practical Guide To Weight Loss And Better Health
7. 18 Powerful Strategies To Prevent Blood Sugar Spikes During The Holidays
8. Applying The Best Behavior Change Techniques At Home For Better Health
9. A Toolbox of Strategies to Prevent Blood Sugar Spikes When Eating High-Glycemic- Index Foods
10. The Blood Sugar Lowering and Metabolic Effects of Vinegar
11. Ways to Lower After-Meal Blood Sugar when Eating White Bread
12. A High-Protein Breakfast Can Lower Blood Sugar the Whole Day
13. Eating rather than skipping breakfast results in lower blood sugars the whole day
14. Pistachios improve insulin resistance and inflammatory markers
15. Pistachios decrease after-meal blood sugar
16. Veggies Meat Carbohydrate Sequence Prevents After Meal Sugar Spike
17. Passing and Failing the One-Hour After-Meal Blood Sugar
18. Low One-Hour Post-Prandial Blood Sugar after One Cup of Rice
19. How often do you do the post-prandial sugar test?
20. Blood Glucose Spike and its Prevention
21. Testing Post Prandial Glucose Level after a Feast
22. Intermittent fasting Reverses Endothelial Dysfunction
23. Walk After Meals to Prevent Sky High Blood Sugars

References:

1. Zhai L, Huo RR, Zuo YL. Atherogenic index of plasma and obesity-related risk of stroke in middle-aged and older Chinese adults: a national prospective cohort study. Diabetol Metab Syndr. 2024 Oct 8;16(1):245. doi: 10.1186/s13098-024-01481-y. PMID: 39380102; PMCID: PMC11462917. https://pubmed.ncbi.nlm.nih.gov/39380102/
2. Xu C, Xu S, Mai P, Tang J, Xu J, Zhang H. Association between the atherogenic index of plasma and abdominal aortic calcification in adults: a cross-sectional study. BMC Public Health. 2024 Sep 6;24(1):2431. doi: 10.1186/s12889-024-19862-3. PMID: 39243068; PMCID: PMC11380399. https://pubmed.ncbi.nlm.nih.gov/39243068/
3. Hohneck A, Weingärtner O. Atherogenic index of plasma – a new frontier in predicting peripheral arterial disease risk? Vasa. 2025 May;54(3):151-153. doi: 10.1024/0301-1526/a001157. PMID: 40321097. https://pubmed.ncbi.nlm.nih.gov/40321097/
4. Qu L, Fang S, Lan Z, Xu S, Jiang J, Pan Y, Xu Y, Zhu X, Jin J. Association between atherogenic index of plasma and new-onset stroke in individuals with different glucose metabolism status: insights from CHARLS. Cardiovasc Diabetol. 2024 Jun 21;23(1):215. doi: 10.1186/s12933-024-02314-y. PMID: 38907337; PMCID: PMC11193183. https://pubmed.ncbi.nlm.nih.gov/38907337/
5. Wu S, Gao Y, Liu W, Wang R, Ma Q, Sun J, Han W, Jia S, Du Y, Zhao Z, Liu Y, Wang Z, Zhou Y. The relationship between atherogenic index of plasma and plaque vulnerabilities: an optical coherence tomography study. Cardiovasc Diabetol. 2024 Dec 18;23(1):442. doi: 10.1186/s12933-024-02532-4. PMID: 39696478; PMCID: PMC11656644. https://pubmed.ncbi.nlm.nih.gov/39696478/
6. Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y, Song X, Xiong Z, Deng L, Li D, Miao S. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025 Jun 14;24(1):254. doi: 10.1186/s12933-025-02784-8. PMID: 40517240; PMCID: PMC12166641. https://pubmed.ncbi.nlm.nih.gov/40517240/
7. Rabiee Rad M, Ghasempour Dabaghi G, Darouei B, Amani-Beni R. The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis. Cardiovasc Diabetol. 2024 Apr 2;23(1):119. doi: 10.1186/s12933-024-02198-y. PMID: 38566139; PMCID: PMC10986012. https://pubmed.ncbi.nlm.nih.gov/38566139/
8. Wu J, Zhou Q, Wei Z, Wei J, Cui M. Atherogenic Index of Plasma and Coronary Artery Disease in the Adult Population: A Meta-Analysis. Front Cardiovasc Med. 2021 Dec 16;8:817441. doi: 10.3389/fcvm.2021.817441. Erratum in: Front Cardiovasc Med. 2023 Mar 08;10:1153914. doi: 10.3389/fcvm.2023.1153914. PMID: 34977202; PMCID: PMC8716758. https://pubmed.ncbi.nlm.nih.gov/34977202/
9. Fernández-Macías JC, Ochoa-Martínez AC, Varela-Silva JA, Pérez-Maldonado IN. Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses. Arch Med Res. 2019 Jul;50(5):285-294. doi: 10.1016/j.arcmed.2019.08.009. Epub 2019 Oct 5. PMID: 31593853. https://pubmed.ncbi.nlm.nih.gov/31593853/
10. Niroumand, Siavash, et al. “Atherogenic Index of Plasma (AIP): A Marker of Cardiovascular Disease.” Medical Journal of the Islamic Republic of Iran, vol. 29, 2015, p. 240. PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC4715400/.

Disclaimer:
This article is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions based on the TyG Index or other biomarkers.

© 2018 – 2025 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment

As an Amazon Associate, I earn from qualifying purchases